thiazoles has been researched along with AIDS-Related Opportunistic Infections in 33 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 22 (66.67) | 18.2507 |
2000's | 9 (27.27) | 29.6817 |
2010's | 2 (6.06) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ambinder, RF; Bender Ignacio, RA; Dittmer, DP; Krown, SE; Lee, JY; Rudek, MA | 1 |
Capparelli, EV; Syed, SS | 1 |
Abraham, DR; Cotton, MF; Rabie, H | 1 |
Cabada, MM; Pantenburg, B; White, AC | 1 |
Rossignol, JF | 2 |
Aslam, S; Musher, DM | 1 |
Nozaki, T | 1 |
Dembele, TM; Diakite, M; Diallo, DA; Doumbo, O; Pichard, E; Rossignol, JF; Traore, F; Traore, HA | 1 |
Clancy, CJ; Nguyen, MH | 1 |
Coleman, DC; Gee, S; Joly, S; Messer, SA; Pfaller, MA; Pujol, C; Soll, DR; Sullivan, DJ | 1 |
Barchiesi, F; Burzacchini, F; Cirioni, O; Dini, M; Giacometti, A; Scalise, G | 1 |
Ancarani, F; Barchiesi, F; Cirioni, O; Giacometti, A; Scalise, G | 1 |
Abboud, P; Ballet, JJ; Borsa-Lebas, F; Brasseur, P; Caron, F; Favennec, L; Gargala, G; Lemée, V | 1 |
Smart, T | 1 |
James, JS | 4 |
Young, A | 2 |
Bornhoeft, MA | 1 |
Bowers, M | 1 |
Cadman, J | 1 |
Baker, R | 1 |
Roehr, B | 1 |
Borowska-Lehman, J; Gross, M; Izycka-Swieszewska, E; Rzepko, R; Zółtowska, A | 1 |
2 review(s) available for thiazoles and AIDS-Related Opportunistic Infections
Article | Year |
---|---|
Treatment of cryptosporidiosis.
Topics: AIDS-Related Opportunistic Infections; Animals; Antiretroviral Therapy, Highly Active; Azithromycin; Biliary Tract Diseases; Coccidiostats; Cryptosporidiosis; Humans; Immunocompromised Host; Nitro Compounds; Paromomycin; Rifamycins; Rifaximin; Thiazoles | 2009 |
[Attention-getting zoonoses: Cryptosporidiosis].
Topics: AIDS-Related Opportunistic Infections; Animals; Antiparasitic Agents; Cryptosporidiosis; Cryptosporidium parvum; Drug Design; Fluid Therapy; Fluorescent Antibody Technique; Humans; Molecular Diagnostic Techniques; Nitro Compounds; Thiazoles; Zoonoses | 2007 |
6 trial(s) available for thiazoles and AIDS-Related Opportunistic Infections
Article | Year |
---|---|
Brief Report: A Phase 1b/Pharmacokinetic Trial of PTC299, a Novel PostTranscriptional VEGF Inhibitor, for AIDS-Related Kaposi's Sarcoma: AIDS Malignancy Consortium Trial 059.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; DNA, Viral; Enzyme Inhibitors; Herpesvirus 8, Human; Humans; Imidazoles; Interleukin-6; Male; Middle Aged; Sarcoma, Kaposi; Thiazoles; Vascular Endothelial Growth Factor A | 2016 |
Nitazoxanide for severe cryptosporidial diarrhea in human immunodeficiency virus infected children.
Topics: AIDS-Related Opportunistic Infections; Animals; Child, Preschool; Coccidiostats; Cryptosporidiosis; Cryptosporidium parvum; Diarrhea; Humans; Infant; Nitro Compounds; Thiazoles | 2008 |
Nitazoxanide in the treatment of acquired immune deficiency syndrome-related cryptosporidiosis: results of the United States compassionate use program in 365 patients.
Topics: Adolescent; Adult; Age Distribution; Aged; AIDS-Related Opportunistic Infections; Antiparasitic Agents; CD4 Lymphocyte Count; Child; Child, Preschool; Cryptosporidiosis; Diarrhea; Feces; Female; Humans; Male; Middle Aged; Nitro Compounds; Sex Distribution; Thiazoles; Time Factors; Treatment Outcome; United States | 2006 |
Nitazoxanide in the treatment of cryptosporidial diarrhea and other intestinal parasitic infections associated with acquired immunodeficiency syndrome in tropical Africa.
Topics: AIDS-Related Opportunistic Infections; Animals; Antiprotozoal Agents; Cryptosporidiosis; Cryptosporidium parvum; Diarrhea; Humans; Intestinal Diseases, Parasitic; Mali; Nitro Compounds; Thiazoles | 1997 |
Ritonavir (Abbott protease inhibitor) proves survival benefit in late-stage AIDS.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; CD4 Lymphocyte Count; Double-Blind Method; HIV Protease Inhibitors; Humans; Ritonavir; Survivors; Thiazoles; Valine | 1996 |
AIDS patients sought for study with NTZ for cryptosporidiosis.
Topics: AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Cryptosporidiosis; Double-Blind Method; Humans; Nitro Compounds; Patient Selection; Placebos; Thiazoles | 1997 |
25 other study(ies) available for thiazoles and AIDS-Related Opportunistic Infections
Article | Year |
---|---|
Nitazoxanide treatment of Cryptosporidium parvum in human immunodeficiency virus-infected children.
Topics: AIDS-Related Opportunistic Infections; Animals; Child, Preschool; Cryptosporidiosis; Cryptosporidium parvum; Diarrhea; HIV Infections; Humans; Infant; Nitro Compounds; Thiazoles | 2008 |
Cryptosporidium and Giardia: treatment options and prospects for new drugs.
Topics: AIDS-Related Opportunistic Infections; Antibodies, Monoclonal; Antiparasitic Agents; Antiretroviral Therapy, Highly Active; Azithromycin; Benzimidazoles; Cryptosporidiosis; Giardia lamblia; Giardiasis; Humans; Nitro Compounds; Nitroimidazoles; Paromomycin; Roxithromycin; Thiazoles | 2010 |
Nitazoxanide: clinical studies of a broad-spectrum anti-infective agent.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Antiparasitic Agents; Humans; Nitro Compounds; Parasitic Diseases; Thiazoles | 2007 |
Comparison of a photometric method with standardized methods of antifungal susceptibility testing of yeasts.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis; Coloring Agents; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Humans; Microbial Sensitivity Tests; Spectrophotometry; Tetrazolium Salts; Thiazoles | 1997 |
In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 1999 |
Efficacy of treatment with paromomycin, azithromycin, and nitazoxanide in a patient with disseminated cryptosporidiosis.
Topics: Adult; AIDS-Related Opportunistic Infections; Animals; Antiprotozoal Agents; Azithromycin; Cryptosporidiosis; Cryptosporidium; Drug Therapy, Combination; Feces; Female; Humans; Nitro Compounds; Paromomycin; Thiazoles; Treatment Outcome | 1999 |
Activity of nitazoxanide alone and in combination with azithromycin and rifabutin against Cryptosporidium parvum in cell culture.
Topics: AIDS-Related Opportunistic Infections; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cell Survival; Cells, Cultured; Cryptosporidiosis; Cryptosporidium parvum; Humans; Nitro Compounds; Rifabutin; Thiazoles | 2000 |
Successful treatment of metronidazole- and albendazole-resistant giardiasis with nitazoxanide in a patient with acquired immunodeficiency syndrome.
Topics: Adult; AIDS-Related Opportunistic Infections; Albendazole; Animals; Antiprotozoal Agents; Drug Resistance, Microbial; Giardia lamblia; Giardiasis; Humans; Male; Metronidazole; Nitro Compounds; Thiazoles; Treatment Outcome | 2001 |
Cryptosporidium clinical trial started.
Topics: AIDS-Related Opportunistic Infections; Anticestodal Agents; Clinical Trials, Phase II as Topic; Cryptosporidiosis; Humans; Nitro Compounds; Thiazoles | 1995 |
Orphan drug designation for NTZ expanded.
Topics: AIDS-Related Opportunistic Infections; Antioxidants; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cryptosporidiosis; Drug Approval; Humans; Immunocompromised Host; Nitro Compounds; Thiazoles; United States; United States Food and Drug Administration | 1997 |
NTZ trials for cryptosporidiosis.
Topics: Adult; AIDS-Related Opportunistic Infections; Anticestodal Agents; Child; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cryptosporidiosis; Diarrhea; Humans; Nitro Compounds; Thiazoles | 1995 |
NTZ: cryptosporidiosis new treatment.
Topics: AIDS-Related Opportunistic Infections; Anticestodal Agents; Clinical Trials as Topic; Cryptosporidiosis; Humans; Thiazoles | 1996 |
Speaking of the runs.
Topics: AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Cryptosporidiosis; Humans; Microsporida; Microsporidiosis; Nitro Compounds; Thiazoles | 1996 |
New products? What new products?
Topics: Acquired Immunodeficiency Syndrome; Adjuvants, Immunologic; AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Cantharidin; Humans; Nitro Compounds; Plants, Medicinal; Thiazoles; Thymopentin | 1996 |
Cryptosporidiosis: NTZ available at buyers' club; customs holds 2nd shipment.
Topics: AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Cryptosporidiosis; Humans; Nitro Compounds; Thiazoles | 1996 |
Incoming NTZ blocked by US customs. People With AIDS Health Group.
Topics: AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Cryptosporidiosis; Drug and Narcotic Control; Humans; Nitro Compounds; Thiazoles; United States | 1996 |
NTZ--we got it.
Topics: AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Cryptosporidiosis; Diarrhea; Humans; Mexico; Nitro Compounds; Thiazoles | 1996 |
NTZ submitted to FDA for cryptosporidiosis. Food and Drug Administration.
Topics: AIDS-Related Opportunistic Infections; Antioxidants; Cryptosporidiosis; Drug Approval; Humans; Nitro Compounds; Thiazoles; United States; United States Food and Drug Administration | 1998 |
Cryptosporidiosis gets a new treatment.
Topics: AIDS-Related Opportunistic Infections; Antiparasitic Agents; Cryptosporidiosis; Diarrhea; Humans; Nitro Compounds; Thiazoles | 1998 |
Nitazoxanide for cryptosporidial diarrhea.
Topics: AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Clinical Trials as Topic; Cryptosporidiosis; Cryptosporidium parvum; Diarrhea; Drug Therapy, Combination; Health Services Accessibility; Humans; Nitro Compounds; Risk Factors; Thiazoles | 1998 |
Prospective case series in clinical trial design--proposal, and NTZ example.
Topics: AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Clinical Trials as Topic; Cryptosporidiosis; Data Collection; Diarrhea; Drug Approval; Ethics, Medical; Humans; Patient Selection; Research Design; Thiazoles | 1998 |
Diarrhea drug rejection raises a ruckus.
Topics: AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Clinical Trials as Topic; Cryptosporidiosis; Diarrhea; Drug Approval; Humans; Thiazoles; United States; United States Food and Drug Administration | 1998 |
FDA panel rejects drug for cryptosporidial diarrhea. Food and Drug Administration.
Topics: AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Clinical Trials as Topic; Cryptosporidiosis; Diarrhea; Drug Approval; Humans; Thiazoles; United States; United States Food and Drug Administration | 1998 |
Another failed promise? NTZ gets the nix.
Topics: AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Clinical Trials as Topic; Cryptosporidiosis; Diarrhea; Humans; Intestinal Diseases, Parasitic; Salvage Therapy; Thiazoles; United States; United States Food and Drug Administration | 1998 |
Vasculopathy and amyloid beta reactivity in brains of patients with acquired immune deficiency (AIDS).
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS Dementia Complex; AIDS-Related Opportunistic Infections; Amyloid beta-Peptides; Axons; Benzothiazoles; Brain; Brain Chemistry; Brain Neoplasms; Cerebral Arteries; Cerebral Veins; Cerebrovascular Circulation; Coloring Agents; Congo Red; Female; Humans; Leukoencephalopathy, Progressive Multifocal; Lymphoma, AIDS-Related; Lymphoma, B-Cell; Male; Meningitis, Cryptococcal; Middle Aged; Plaque, Amyloid; Thiazoles; Toxoplasmosis, Cerebral; Ubiquitin; Vasculitis | 2000 |